Givastomig
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Givastomig, covering 2026-02-25 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]